Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
doi:10.1016/S2213-8587(19)30194-9 47
The parent trials primary endpoint was change in visceral adipose tissue, with secondary cardiometabolic and body-composition endpoints
This results in feeling fuller, longer, reducing your appetite and thoughts of food
Injection site reactionssuch as redness, itching, or mild discomfort at the injection siteare typically minimal but can occur
Finally, most of the included trials recruited patients from the USA, Europe, and some Asian countries, which limits the generalizability of the results across all ethnic groups
US$ 28.03
US$ 26.25
US$ 26.68
US$ 29.86
US$ 26.38
